Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03085511 · ClinicalTrials.gov registry record · NA
High Quality Protein for Assisting With Weight Loss
A NA study, sponsored by Texas Tech University.
- Completed
- Registry status
- NA
- Development phase
- 40
- Enrollment target
NCT03085511: Completed NA study, sponsored by Texas Tech University.
NCT03085511 is a NA study that has completed, run by Texas Tech University. The registered enrollment target is 40 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03085511, a NA study, has completed, sponsored by Texas Tech University.
- COMPLETED
- Registry status
- NA
- Development phase
- 40 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if, in presence of a reduced calorie diet, a breakfast containing high quality protein source (eggs) would be more effective in reducing hunger and increasing feeling of fullness compared to a breakfast containing a lower quality of protein, but equal energy density. A previous pilot study with the same endpoints yielded borderline significant results; this study has been powered based on that pilot to interrogate our hypotheses.
Primary Outcome
This will be measured by questionnaire (VAS) and compared the changes between 2 test days (day 7 and day 14) in experiment 1\&2
Interventions
- BEHAVIORAL Egg breakfast (EB)
- BEHAVIORAL Weight Loss Counseling
- BEHAVIORAL Weight Loss Diet
- BEHAVIORAL Cereal Breakfast (CB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 40 participants |
| Start Date | 2017-08-20 |
| Est. Completion | 2019-05-17 |
| Phase | NA |
What the finished NCT03085511 record still lists
NCT03085511 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 40 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 4 interventions - of which Egg breakfast (EB) is the first listed.
NCT03085511 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03085511 about?
NCT03085511 is a clinical study titled "High Quality Protein for Assisting With Weight Loss". The purpose of this study is to determine if, in presence of a reduced calorie diet, a breakfast containing high quality protein source (eggs) would be more effective in reducing hunger and increasing feeling of fullness compared to a breakfast containing a lower quality of protein, but equal energy...
What is the current status of trial NCT03085511?
This trial is currently completed. It is a NA study. The enrollment target is 40 participants. The study started on 2017-08-20. Estimated completion is 2019-05-17.
What interventions are being tested in trial NCT03085511?
The interventions under investigation include: Egg breakfast (EB) (BEHAVIORAL), Weight Loss Counseling (BEHAVIORAL), Weight Loss Diet (BEHAVIORAL), Cereal Breakfast (CB) (BEHAVIORAL).
Who is sponsoring clinical trial NCT03085511?
This trial is sponsored by Texas Tech University, which has 69 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03085511's enrollment target sits among peer trials
40 1447th of 2000 higher than 465 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01306019 · 40 participants · Phase 1
Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)
- NCT01608152 · 40 participants
Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors
- NCT01668082 · 40 participants · NA
An Investigation of Brain Tumor Metabolism in Patients Undergoing Surgical Resection
- NCT02015013 · 40 participants · Phase 2
Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI